Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Consensus
14 (
02
); 135-142
doi:
10.1055/s-0045-1806763

Setting Up Geriatric Oncology Clinical Services: Asian Geriatric Oncology Society Guidelines 2025 (Part 1)

Department of Clinical Hematology, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India
Department of Field Operations, Program for Global Health, Aging and Policy, CESD, University of Southern California, Los Angeles, California, United States
Department of Geriatric Oncology, Gericare Hospital, Chennai, Tamil Nadu, India
Department of Geriatrics, MOC, Mumbai, Maharashtra, India
Department of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India
Department of Medical Oncology, Air Force Hospital, Bengaluru, Karnataka, India
Author image
Corresponding author: Purvish M. Parikh, MD, DNB, FICP, PhD, ECMO, CPI, Sitapura, Jaipur 302022, Rajasthan, India. purvish1@gmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

In this article, the Asian Geriatric Oncology Society provides an overview on how to develop geriatric oncology services in the clinical setting. This overview gives an insight into the rationale; key stakeholders; four essential components of the services; multidisciplinary team and tumor boards; assessment and screening protocols; data, research, and audit; professional education, development, and training; and communication, awareness and social medial utilization. In the second part of the article, we focus on optimizing resource utilization in constrained settings—dividing them into “must have” and “good to have.”

Keywords

PubMed

Introduction

Life expectancy is increasing globally. Even among low- and middle-income countries (LMICs), public health initiatives against communicable diseases have led to the people living longer. This has resulted in increase in lifestyle diseases, including cancer, cardiac ailments, and diabetes mellitus, among others. Technological advances have also led to more effective treatment options with a corresponding increase in disease-free survival and even cure.1 This has also brought out new challenges. Older people are not the same as young active productive working adults. Age has its prerequisite consequences. Although chronological age need not necessarily be in sync with biological age, the age-related telomere length reduction has far-reaching consequences.2 The spectrum ranges from subclinical attenuation of organ function reserve to gross manifestations of geriatric syndromes. Geriatric oncology services aim to provide optimal personalized care for older patients with cancer.3

Rationale for Geriatric Oncology Clinical Services: Recommendations by the AGOS

The complexity in the management of cancer patients is increasing. Treatment options are multiplying, biomarkers are enabling the identification of population likely to benefit, and treatment guidelines are providing a bouquet of standard treatments that allow selection based on patient features and preferences. Technological advances have also resulted in new and sometimes unpredictable toxicities.

An older person is different from his or her younger, fitter version. Comorbidities, polypharmacy, and metabolic and circulatory changes all gnaw at the elasticity, agility, and regenerative capacity of the cells and organs. Geriatric syndromes, fragility, sarcopenia, and mobility limitations reduce the capacity of the cells, organ, and body to tolerate the abuse and consequences of anticancer therapy.

Walking the tight rope where the therapeutic window is even narrower is challenging. This requires a team with collective expertise, experience, and insights. The dynamics are constantly changing. Newer options become available under the standard of care guidelines. The duration of therapy keeps increasing too. Patients live longer, often with operational cure that requires the right sequencing of drug combinations. In addition, drug–drug interactions add to the complexity. Artificial intelligence tools allow faster, comprehensive, and more accurate selection—to a point. However, the buck finally stops at the treating medical team.

When geriatricians and oncologists work together, their collective expertise increase the benefits exponentially. We even have India-specific validated tools Screening of the Older Person with Cancer (SCOPE-C) for geriatric assessment and prediction of tolerance of individual older patients.4 This allows personalizing and fine-tuning the treatment so as to reduce toxicity and increase survival. It is now well established that having a geriatric oncology service within a medical establishment benefits older patients, in terms of cure, survival, quality of life, and patient satisfaction.35

Key Stakeholders, Common Goal, and Addressing a Vital Unmet Need

Geriatric oncology services have a common goal that needs a multidisciplinary team (MDT). Key stakeholders that can provide inputs and expertise to any geriatric oncology service are shown in Fig. 1. Even with optimal availability of resources, this is a complex endeavor. Not all are required and/or available at all times/facilities. This is particularly true for a specialty that is still evolving. Fortunately, with almost half of the newly diagnosed cancer patients being in the senior citizen age group, even the fence sitters and skeptics in the hospital administration are beginning to recognize the value of providing such services. A well-thought-out plan that outlines specifics of ethical, medical, social, and financial benefits in setting up geriatric oncology services is essential. Initially there will be teething problems. However, we need to be resolved to overcome them. Care that is currently being offered in a knee-jerk, haphazard, fragmented, and suboptimal manner will slowly transform into the intended multidisciplinary approach. The ripple effect will then enthuse key stakeholder and the attract the community to take advantage of the facilities being offered.

Key stakeholders in a geriatric oncology clinical service. NGOs, nongovernmental organizations.
Fig. 1: Key stakeholders in a geriatric oncology clinical service. NGOs, nongovernmental organizations.

Components

An ideal geriatric oncology service can be divided into outpatient services, inpatient services, community outreach programs, and virtual/digital offerings.6

Outpatient Services

When a new facility or service is being made available, the team needs to be flexible, willing to adapt quickly, and make temporary arrangements to fill any gaps. Consistency and winning the trust of the patients is key to success.7 For this, attention has to be paid to the following:

  • Clearly defined location, timing, human resource allocation.

  • Change the availability based on patient flow/load (projected patient weekly visits—new and follow-up).

  • Plan to modify based on dynamic requirements—will need to expand once patient and service load increases.

  • One-stop facilitation—since geriatric patients have even greater difficulty in moving from place to place within the health care facility. Tools required for geriatric assessment to be available inhouse.

  • Coordinate scheduling and location of services in proximity to and based on availability of members of the MDT.

  • Ensure availability of ancillary service providers (e.g., phlebotomist).

  • Smooth patient management flow based on time and motion studies.

  • Dedicated data management and research infrastructure.

Inpatient Services

Referring health care professionals are usually smart and can quickly determine the value addition that the geriatric oncology team is able to deliver. They will then decide whether it is worth taking the extra effort to involve the geriatric oncologists and when to involve them. To be successful, the geriatric oncology service should have a simple and intuitive process for geriatric oncology referrals.8 They should also be dealt with promptly including giving feedback to the one referring the patient. Close liaison within the team and with outside stakeholders is essential. When specialized investigations or procedures are required, the standard operating procedure (SOP) should be followed diligently. The entire process and success stories also need to be publicized among all stakeholders. Collecting results and sharing success stories are the key to getting a buy-in from colleagues from other departments, especially the oncology and geriatric departments.

Community Outreach Programs

The service should plan a phase-wise outreach in the community.9 This should include doctors practicing in the vicinity or drainage area of the institution. Special attention should be paid to general practitioners and internal medicine specialists. They should be made aware that symptoms and complaints that older patients present with (e.g., weight loss, anorexia, pain) are not be presumed simply because of the normal aging process. They should be given guidelines on how to pursue a high index of suspicion for the overlap between geriatric issues and warning signs of malignancy. They should be made aware that an early referral to the geriatric oncology service can improve survival as well as quality of life—even in older patients. Awareness programs should also be organized for community leaders and nongovernmental organizations (NGOs; e.g., Lions, Rotary, Big Corporates, Ethnic groups). Dates for such activities should be carefully selected to maximize interest and participation from the community, for example, breast cancer day.

Virtual/Digital Offerings (See section on Communication, Awareness, and Social Media Utilization below)

The internet, data services, and smartphones are everywhere. The general population uses all possible avenues, including artificial intelligence tools (like ChatGPT and Meta AI), to find health care solutions that meet their expectations. Being visible online in the digital world, updating posts, and making it easier for geriatric oncology patients to find you are the need of the hour.10 Facebook, X (formerly twitter), YouTube, Instagram, and LinkedIn posts should complement an exclusive Web site. Customized apps and services can enhance the value of the services provided. When integrated into the hospital electronic medical records, they provide a seamless platform to communicate with the patients.

We know that 60% of Indian health care services cater to 30% of our population, mainly in the urban areas. The internet, social media, and digital solutions have the potential to overcome these challenges, especially with the use of telemedicine specifically catering to senior citizens.11 It could also help reduce hospitalization for geriatric oncology patients. About 80% of such patients coming to an oncology center have a mobile phone. The number of patients having smartphones with internet access is lower, at approximately 30%. Only a quarter of patients actually access the internet and/or social media. Limitations include literacy, female gender, access to data signal, arthritis, visual impairment, and aversion to anything that is unfamiliar (Table 1).11112

Table 1
Digital services for geriatric oncology patients 11112

Sl. no.

Limitation

Potential solution

1

Older patients tend to be less familiar with digital and social media technology

Apps and platforms should be simple

2

Visual limitation

Use larger font

3

Arthritis

Avoid need to scroll or toggle from one screen to another

4

Intermittent electricity

Solar energy

5

Language barrier

Availability in multiple languages

6

General aversion or reluctance

Mobilize social support through younger family members, neighbors, and friends

The solution could lie with their accompanying caregivers. Almost all (99%) have a mobile phone and three-fourths access internet and/or social media. India and other LMICs are known to have a very supportive social structure, especially in rural areas. Younger relatives, friends, and neighbors chip in during times of need. Geriatric oncology patients can easily overcome technology barriers with the help of this informal but robust support system.

Maintaining a dynamic and updated social media presence at regular intervals is key to a successful online offering.1

Multidisciplinary Team Meetings

MDT meetings form a vital component to the functioning and success of geriatric oncology services. Each patient should be evaluated in a systematic manner using evidence-based medicine (Fig. 1).3513 It should be used as a platform to informally educate oncologists, geriatricians, and other health care personnel in the hospital about the explosion of geriatric oncology data/published evidence. It should also explain the rationale behind the individualized management of geriatric issues among cancer patients and highlight success stories where patient treatment plans differed from younger adults and how this change benefited them. The inputs from all members of the MDT should be heard patiently, given due importance, documented, used to modify patient management plans, and finally incorporated in policy decisions that enhance the value of geriatric oncology services. The proceedings of the MDT should be documented, and the decisions should be shared with the concerned members.

Assessment and Screening Protocols

There are several publications, guidelines, recommendations, and tools used for geriatric oncology patients.414151617181920212223 The spectrum ranges from screening tools to comprehensive detailed evaluation. Based on the institutional requirements, departmental service SOPs, patient load, and infrastructure/resource availability protocols should be selected and used from time to time and on a case-to-case basis. For instance, the G8 screening tool could be used in all new patients and the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score used for patients planned for chemotherapy. It is preferable to use protocols that have been developed and validated in our/similar patients, like SCOPE-C.

There should also be guidelines of how young adult cancer protocols can be modified based on the geriatric assessment.

A representative list of such protocols is given in Table 2.

Table 2
Representative sample of commonly used geriatric screening tools in oncology patients414151617181920212223

SCOPE-C

Only tool devised and validated among Indian geriatric oncology patients (comprehensive assessment of 8 domains with clear cutoff predicting outcome)

Banerjee et al4

VES-13

Age, self-rated health, three questions on functionality (total 6Q)

Saliba et al20

G8

7 Q from the MNA scale, 1 Q on age (total 8 Q)

Bellera et al21

Abbreviated comprehensive geriatric assessment (CGA)

3 Q on ADL, 4 Q on IADL, 4 Q on GDS, 4 Q on MMSE (total 15Q)

Overcash et al22

Brief CGA

Domains: functional, comorbidity, cognition, psychologic, social support, social functioning, nutrition

Hurria et al19

Oncogeriatric screen (OGS)

2 Q on autonomy, 2 Q on depression, 2 Q on cognition, 2 Q on nutrition, 1 Q each on comorbidity and polypharmacy (total 10 Q)

Valero et al23

Flemish version of the Triage Risk Screening Tool (fTRST)

A score of ≥2 indicates high-risk patients within the geriatric population

A score of ≥1 is considered a high geriatric risk profile within the oncologic population

Prognostic for functional decline during therapy and higher mortality rates

Fagard et al15

Chemotherapy Risk Assessment Score for High Age Patients (CRASH)

Twenty-four parameters for assessing average per-patient risk of chemotherapy toxicity

Extermann et al16

Cancer and Aging Research Group (CARG)

Three items for health care providers and six items for patients

Hurria et al19

SCOPE-C is the only tool devised and validated in the Indian population.4 It was developed by Banerjee et al and has been demonstrated to have a clear cutoff score to predict tolerability of cancer-directed therapy (Fig. 2). It also correlates with survival. In the socioeconomic context of the India and LMICs as well as resource-limited settings, it is the first screening tool that we recommend.

Algorithm for risk scoring and treatment modification using the SCOPE-C tool.
Fig. 2: Algorithm for risk scoring and treatment modification using the SCOPE-C tool.

The workflow of patients should also be streamlined. Usually, a patient suspected to have cancer (at any age) is referred to the oncology department. They should also undergo a comprehensive evaluation by a geriatrician, preferably with oncology interest/experience. Older patients with the presumed diagnosis of geriatric syndromes/problems/multiple morbidities are referred to the geriatric departments. Once the diagnosis of a malignancy is confirmed, they should be referred to the appropriate oncologist, preferably with geriatric interest/experience. As the setting up of the geriatric oncology services progresses, an MDT (as shown in Fig. 1) should provide a 360-degree service to the geriatric oncology patient and all such patients should also be discussed in the Multidisciplinary Team (MDT) prior to initiation of therapy.

Data Collection, Research, and Audit

In today's day and age, it is a regulatory requirement to maintain patient medical records.24 The institutional SOP for the same needs to be followed. In addition, geriatric oncology–related data should be collected and preserved so as to allow a rapid and accurate audit. Ultimately, it is our objective to improve patient outcome, and a predetermined process should be in place to find out whether this goal is being achieved or not. Sufficient infrastructure and human resource should be developed to ensure this in the long term.

Geriatric oncology has several gray areas and unmet needs.3 Hence, research will be of immense value, even at the global level. The Asian Geriatric Oncology Society (AGOS) actively encourages research and publication.13 It is also a part of the AGOS Vision 25 by 25. A snapshot of some of the important publications in geriatric oncology from India are listed in Table 3.13451718252627282930

Table 3
Snapshot of key publications in Geriatric Oncology from India13451718252627282930

Author

Title

Journal, year

Vijaykumar et al

Geriatric oncology: the need for a separate subspecialty

IJMPO, 2012

Vora et al

Geriatric oncology in India: a data on patient profile from one of the cancer centers in North India

Journal of Geriatric Oncology (JGO), 2012

Sarkar and Shahi

Assessment of cancer care in Indian elderly cancer patients: a single center study

SAJC, 2013

Patil et al

Patterns of care in geriatric cancer patients: an audit from a rural based hospital cancer registry in Kerala

IJC, 2015

Banerjee et al

CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker

Clinical and Translational Oncology, 2017

Parikh et al

Geriatric oncology landscape in India: current scenario and future projections

CRST, 2020

Banerjee et al

A short geriatric assessment tool for the older person with cancer in India: development and psychometric validation

JGO, 2019

Ostwal et al

Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study

Geriatric Medicine, 2021

Banerjee et al

Lung cancer in the older population: Interactive effects of angiotensin converting enzyme gene polymorphism (rs 4340 ID) and tobacco addiction in risk assessment

Indian Journal of Cancer, 2021

Kandel et al

Challenges in management of the older patients with cancer: report from a low- and- middle income country

Journal of Indian Academy of Geriatrics (JIAG), 2021

Banerjee et al

Implementing and validating a care protocol for older adults with cancer in resource limited settings with a newly developed screening tool

JGO, 2021

Noronha et al

Impact of the geriatric assessment on cancer-directed systemic therapy in older Indian persons with cancer: an observational study

CRST, 2022

Soni et al

Health-related quality of life in treatment-naive, older patients with cancer from India: a prospective observational study

CRST, 2022

Shah et al

G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer

JGO, 2022

Noronha et al

The current status of geriatric oncology in India

Ecancer, 2023

Swamy et al

Improving care for older adults with hematological malignancies in India: conquering the challenge

JGO, 2023

Sankarapillai et al

Epidemiology of cancers among older adults in India: findings from the National Cancer Registry Program

Public Health, 2023

Pathi et al

Unmet needs in geriatric oncology

SAJC, 2023

Kumar et al

An analysis of psychological problems in older Indian patients with cancer

JGO, 2024

Rao et al

Assessing frailty in older Indian patients before cancer treatment: comparative analysis of three scales and their implications for overall survival

JGO, 2024

Sansar et al

At crossroads: the challenges for geriatric oncology in India

SAJC, 2024

Akhade et al

Geriatric oncology in LMICs: it is time to mature

BMC Geriatrics, 2024

Rao et al

Assessing frailty in older Indian patients before cancer treatment: comparative analysis of three scales and their implications for overall survival

JGO, 2024

Professional Education, Development, and Training

Regular teaching and training of junior doctors and nurses is also a fundamental responsibility in geriatric oncology. Rounds of inpatients, teaching rounds, journal clubs, case presentations, seminars, and workshops should be done from time to time.35 Creating awareness regarding the geriatric oncology service among other departments in the hospital as well as new developments in the field is encouraged. Data should also be presented in local, state, national, regional, and international conferences as appropriate. Centers are also encouraged to take advantage of certificate courses, workshops, seminars, and training courses offered by the AGOS.13 Fellowships and degree courses in geriatric oncology can also be developed as part of the long-term plan. The AGOS will provide a formal curriculum/syllabus to interested members.

Communication, Awareness, and Social Media Utilization (See also section on Virtual/Digital Offerings above)

Just because a service is available does not necessarily mean that its intended beneficiary will be referred to you. It requires planning. Key stakeholders whose inputs need to be taken before the service is officially made available include institution administration, key medical departments that should refer suitable patients, and other stakeholders whose active participation is vital to making the service successful. This will also help in understanding their expectations and modifying the plan as required. A vibrant inauguration at the hands of the senior-most person in the institution is helpful. This will also ensure that the public relation and marketing departments of the institution help disseminate the information. A circular signed by the dean/principal and sent to all faculty members of the institution will complement the inauguration. Special brief in-person speeches should be planned for allied health care staff likely to be involved in the care of these patients, for example, nurses, pharmacists, and day care personnel. For the department of oncology and geriatric medicine, a more detailed and sustained interaction needs to be performed—taking care to outline how this new department will not infringe or encroach on their existing priority areas. Face-to-face/one-on-one interactions are important to resolve stumbling blocks and remove misconception.

Availability of geriatric oncology services should also be publicized outside the institution. The use of institutional marketing personnel and social media plays an important role. Spreading the message that this service shall facilitate longevity will be a positive communication strategy. Once the service gains traction, endorsement by patients who are happy with their experience will be independent validation. Care should be taken that this is done directly by patients in compliance with applicable regulations and keeping in mind the need to preserve confidentiality.

The importance of the right communication strategy, good communication skills, and judicious use of social media cannot be overemphasized.31

Conclusion

Geriatric oncology is here to stay as a vital specialty, since about half of all cancer patients belong to the older (geriatric) age group. Geriatricians and oncologists come together to provide personalized care to patients based on their individual characteristics and preferences, in the setting of a dedicated geriatric oncology service. Such an approach has been proven to reduce toxicity and optimize survival. This requires an in-depth patient assessment and fine-tuning of protocols normally used in younger adults. A lot of research and publications support this conclusion. Yet, several areas of unmet needs exist—providing an excellent opportunity to do research that will have worldwide application. Those who take up this specialty as their professional path are likely to move forward quickly and have the satisfaction of having recognized the potential of a growing field.

References

  1. , , , . Making the seniors tech savvy: the way forward to bringing cancer care to the doorstep. Cancer Res Stat Treat. 2022;5:163-164.
    [Google Scholar]
  2. , , , et al . Unravelling the role of telomere shortening with ageing and their potential association with diabetes, cancer, and related lifestyle factors. Tissue Cell. 2022;79:101925.
    [Google Scholar]
  3. , , , , , , . Unmet needs in geriatric oncology. South Asian J Cancer. 2023;12(02):221-227.
    [Google Scholar]
  4. , , , et al . Implementing and validating a care protocol for older adults with cancer in resource limited settings with a newly developed screening tool. J Geriatr Oncol. 2021;12(01):139-145.
    [Google Scholar]
  5. , , , , , . Geriatric oncology landscape in India: current scenario and future projections. Cancer Res Stat Treat. 2020;3(02):296-299.
    [Google Scholar]
  6. , , , , , , . The role of geriatric oncology in the care of older people with cancer: some evidence from Brazil and the world. Rev Assoc Med Bras. 2024;70:S118.
    [Google Scholar]
  7. , , , et al . Economic evaluation of a geriatric oncology clinic. Cancers (Basel). 2022;14(03):789.
    [Google Scholar]
  8. , , , , , , . Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns. J Clin Oncol. 2003;21(24):4627-4635.
    [Google Scholar]
  9. , . Integration of geriatrics in oncology training: the relationship between the academic center and the community. Crit Rev Oncol Hematol. 2000;33(01):57-59.
    [Google Scholar]
  10. , , , et al . Age differences in patterns and confidence of using internet and social media for cancer-care among cancer survivors. J Geriatr Oncol. 2020;11(06):1011-1019.
    [Google Scholar]
  11. , , , et al . Telemedicine in geriatric oncology is here to stay. Front Med (Lausanne). 2024;11:1439975.
    [Google Scholar]
  12. Sukino. The Effects of Social Media on the Elderly. 2024. Accessed January 22, 2025 at:
  13. The Hindu. Geri Care hosts first Asian Geriatric Oncology Society Conference in Chennai. 2024. Accessed January 22, 2025 at:
  14. , , , et al . Exploring cost-effectiveness of the comprehensive geriatric assessment in geriatric oncology: a narrative review. Cancers (Basel). 2022;14(13):3235.
    [Google Scholar]
  15. , , , et al . Value of geriatric screening and assessment in predicting postoperative complications in patients older than 70 years undergoing surgery for colorectal cancer. J Geriatr Oncol. 2017;8(05):320-327.
    [Google Scholar]
  16. , , , et al . Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;118(13):3377-3386.
    [Google Scholar]
  17. , , , et al . Assessing frailty in older Indian patients before cancer treatment: comparative analysis of three scales and their implications for overall survival. J Geriatr Oncol. 2024;15(03):101736.
    [Google Scholar]
  18. , , , et al . G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer. J Geriatr Oncol. 2022;13(05):720-730.
    [Google Scholar]
  19. , , , et al . Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J Clin Oncol. 2016;34(20):2366-2371.
    [Google Scholar]
  20. , , , et al . The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691-1699.
    [Google Scholar]
  21. , , , et al . Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(08):2166-2172.
    [Google Scholar]
  22. , , , , . The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol. 2005;54(02):129-136.
    [Google Scholar]
  23. , , , et al . F-OGS, a new “Follow-up Onco-Geriatric Screening” tool during the follow-up of older patients undergoing oncological treatment. Pilot study of feasibility and acceptability. J Geriatr Oncol. 2022;13(03):315-317.
    [Google Scholar]
  24. , . Ayurvedic doctors cannot prescribe allopathic medicines: National Consumer Dispute Redressal Commission judgement. South Asian J Cancer. 2023;12(02):100-103.
    [Google Scholar]
  25. , , , , , . Geriatric oncology: the need for a separate subspecialty. Indian J Med Paediatr Oncol. 2012;33(02):134-136.
    [Google Scholar]
  26. , , , . Geriatric oncology in LMICs: it is time to mature. BMJ Oncol. 2024;3(01):e000537.
    [Google Scholar]
  27. , , , et al . At crossroads: the challenges for geriatric oncology in India. South Asian J Cancer 2024
    [Google Scholar]
  28. , , , , . Improving care for older adults with hematological malignancies in India: conquering the challenge. J Geriatr Oncol. 2023;14(06):101536.
    [Google Scholar]
  29. , , , et al . Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study. BMJ Open. 2021;11(06):e047376.
    [Google Scholar]
  30. , , , et al . Challenges and determinants in the management of the older patients with cancer: report from a low- and middle-income country. J Indian Acad Geriatr. 2021;17:2-8.
    [Google Scholar]
  31. , , , . Social media and health communication: a review of advantages, challenges, and best practices. Hershey, PA: IGI Global; .
Show Sections